Increasing high-sensitive C-reactive protein level predicts peritonitis risk in chronic peritoneal dialysis patients

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Su, Yu Jen ^a   Liao, Shang Chih ^a   Cheng, Ben Chung ^a   Hwang, Jyh Chang ^b   Chen, Jin Bor ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

High sensitivity C reactive protein; Peritoneal dialysis; Peritonitis

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BIOCHEMISTRY; CASE CONTROL STUDY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HAZARD RATIO; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PERITONITIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CAUSALITY; COMORBIDITY; CROSS-SECTIONAL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERIOSTITIS; PERITONEAL DIALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TAIWAN; YOUNG ADULT;

EID: 84883304925     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-185     Document Type: Article

References (29)

1. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Rifai N, Tracy RP, Ridker PM, Clin Chem 1999 45 2136 2141 10585345
2. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. Hackam DG, Anand SS, JAMA 2003 290 932 940 10.1001/jama.290.7.932 12928471 (Pubitemid 37430466)
3. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierrez A, Heimbürger O, Lindholm B, Bergström J, J Am Soc Nephrol 2002 13 suppl 1 28 S36 11792759
4. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Iseki K, Tozawa M, Yoshi S, Fukiyama K, Nephrol Dial Transplant 1999 14 1956 1960 10.1093/ndt/14.8.1956 10462277 (Pubitemid 29358894)
5. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Yeun JY, Levine RA, Mantadilok V, Kaysen GA, Am J Kidney Dis 2000 35 469 476 10.1016/S0272-6386(00)70200-9 10692273 (Pubitemid 30124077)
6. Persistent elevation of C-reactive protein and ischemic heart disease in patients with continuous ambulatory peritoneal dialysis. Kim SB, Min WK, Lee SK, Park JS, Hong CD, Yang WS, Am J Kidney Dis 2002 39 342 346 10.1053/ajkd.2002. 30554 11840375 (Pubitemid 34174257)
7. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients? Wang AY, Woo J, Lam CW, Wang M, Sea MM, Lui SF, Li PK, Sanderson J, J Am Soc Nephrol 2003 14 1871 1879 10.1097/01.ASN.0000070071. 57901.B3 12819248 (Pubitemid 36750483)
8. Peritonitis as a complication of peritoneal dialysis. Piraino B, J Am Soc Nephrol 1998 9 1959 1964
9. Determinants of albumin concentrations in hemodialysis patients. Kaysen GA, Stevenson FT, Depner TA, Am J Kidney Dis 1997 29 658 668 10.1016/S0272-6386(97)90117-7 9159298 (Pubitemid 27209666)
10. Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients? Herzig KA, Purdie DM, Chang W, Brown AM, Hawley CM, Campbell SB, Sturtevant JM, Isbel NM, Nicol DL, Johnson DW, J Am Soc Nephrol 2001 12 814 821 11274243 (Pubitemid 32246710)
11. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH, N Engl J Med 1997 336 973 979 10.1056/NEJM199704033361401 9077376 (Pubitemid 27152782)
12. C-reactive protein and cardiovascular disease in peritoneal dialysis patients. Ducloux D, Bresson-Vautrin C, Kribs M, Abdelfatah A, Chalopin JM, Kidney Int 2002 62 1417 1422 10.1111/j.1523-1755.2002.kid562.x 12234314
13. Chronic inflammation in peritoneal dialysis: the search for the holy grail? Pecoits-Filho R, Stenvinkel P, Wang AY, Heimbürger O, Lindholm B, Perit Dial Int 2004 24 327 339 15335146 (Pubitemid 39206627)
14. Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients. Yeun JY, Kaysen GA, Am J Kidney Dis 1997 30 923 927 10.1016/S0272-6386(97)90105-0 9398142 (Pubitemid 27524361)
15. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL, Am J Kidney Dis 1998 32 107 114 10.1053/ajkd.1998.v32.pm9669431 9669431 (Pubitemid 28311878)
16. Causes of low serum albumin in peritoneal dialysis patients. Yeun JY, Int J Artif Organs 2000 23 149 153 10795657 (Pubitemid 30223771)
17. Effect of the hemodialysis membrane on the inflammatory reaction in vivo. Schindler R, Boenisch O, Fischer C, Frei U, Clin Nephrol 2000 53 452 459 10879665 (Pubitemid 30390075)
18. Inflammation and cardiovascular risk in dialysis patients. Wanner C, Zimmermann J, Schwedler S, Metzger T, Kidney Int 2002 61 Suppl 80 99 S102 11841621
19. Oxidative stress in chronic renal failure. Galle J, Nephrol Dial Transplant 2001 16 2135 2137 10.1093/ndt/16.11.2135 11682656 (Pubitemid 33062132)
20. Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Danielski M, Ikizler TA, McMonagle E, Kane JC, Pupim L, Morrow J, Himmelfarb J, Am J Kidney Dis 2003 42 286 294 10.1016/S0272-6386(03)00653-X 12900810 (Pubitemid 36944436)
21. Reduced oxidative stress in hypoalbuminemic CAPD patients. Kim SB, Yang WS, Min WK, Lee SK, Park JS, Perit Dial Int 2000 20 290 294 10898045 (Pubitemid 30497166)
22. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of creactive protein. Verma S, Li SH, Badiwala MV, Weisel RD, Fedak PW, Li RK, Dhillon B, Mickle DA, Circulation 2002 105 1890 1896 10.1161/01.CIR.0000015126.83143.B4 11997273 (Pubitemid 34437614)
23. Hyperleptinaemia and chronic inflammation after peritonitis predicts poor nutritional status and mortality in patients on peritoneal dialysis. Lam MF, Leung JC, Lo WK, Tam S, Chong MC, Lui SL, Tse KC, Chan TM, Lai KN, Nephrol Dial Transplant 2007 22 1445 1450 10.1093/ndt/gfl788 17277343 (Pubitemid 47072235)
24. Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells. Yung S, Chan TM, Mediators Inflamm 2012 2012 484167 22577250
25. Intrinsic cells: mesothelial cells-central players in regulating inflammation and resolution. Yung S, Chan TM, Perit Dial Int 2009 29 suppl 2 21 S27 19270220
26. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival. Snaedal S, Heimbürger O, Qureshi AR, Danielsson A, Wikström B, Fellström B, Fehrman-Ekholm I, Carrero JJ, Alvestrand A, Stenvinkel P, Bárány P, Am J Kidney Dis 2009 53 1024 1033 10.1053/j.ajkd.2009. 02.008 19394732
27. The prognostic impact of fluctuating levels of C-reactive protein in Brazillan hemodialysis patients: a prospective study. Nascimento MM, Pecoits-Filho R, Qureshi AR, Hayashi SY, Manfro RC, Pachaly MA, Renner L, Stenvinkel P, Lindholm B, Riella MC, Nephrol Dial Transplant 2004 19 2803 2809 10.1093/ndt/gfh493 15496560 (Pubitemid 39480976)
28. The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular moertality in patients starting with dialysis. Den Elzen WP, Van Manen JG, Boeschoten EW, Krediet RT, Dekker FW, Nephrol Dial Transplant 2006 21 1588 1595 10.1093/ndt/gfk092 16449284 (Pubitemid 43834640)
29. Trimestral variation patterns of C-reactive protein, interleukin-6 and tumor necrosis factor-α are similarly associated with survival in hemodialysis patients. Meuwese CL, Snaedal S, Halbesma N, Stenvinkel P, Dekker FW, Qureshi AR, Barany P, Heimburger O, Lindholm B, Krediet RT, Boeschoten EW, Carrero JJ, Nephrol Dial Transplant 2011 26 1313 1318 10.1093/ndt/gfq557 20846939